Value, affordability and decision making

Research & Publications
News & Insights
Education
Innovation Policy Prize

Latest Research & Publications

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

#image_title

An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

$Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) report cover$

News
April 2016

New Publication: Opportunity Costs and Local Health Service Spending Decisions – A Qualitative Study from Wales

News
April 2016

New OHE Consulting Report on Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

News
April 2016

OHE Response: The National PROMs Programme Consultation

An-EQ-5D-5L-Value-Set-for-England-small-tiny

News
April 2016

Care at the End of Life: An Economic Perspective

News
March 2016

OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples

News
March 2016

New OHE Publications: An EQ-5D-5L Value Set for England

News
February 2016

Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?

News
February 2016

New ISPOR Task Force Report on Multiple Criteria Decision Analysis

News
January 2016

From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers

News
January 2016

Seminar at Glasgow Caledonian University: Local Health Care Expenditure Plans and Their Opportunity Costs

Latest Research & Publications

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?

Policy Options for Formulary Development in Middle-income Countries

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics

An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

Extrapolation from Progression-Free Survival to Overall Survival in Oncology

All Publications

Filter results by

Filter results by

New Publication: Opportunity Costs and Local Health Service Spending Decisions – A Qualitative Study from Wales

New OHE Consulting Report on Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

OHE Response: The National PROMs Programme Consultation

Care at the End of Life: An Economic Perspective

OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples

New OHE Publications: An EQ-5D-5L Value Set for England

Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?

New ISPOR Task Force Report on Multiple Criteria Decision Analysis

From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers

An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Seminar at Glasgow Caledonian University: Local Health Care Expenditure Plans and Their Opportunity Costs

Uncertainty and Risk in HTA Decision Making

Share on Mastodon